Compare · CBUS vs SNES
CBUS vs SNES
Side-by-side comparison of Cibus Inc. (CBUS) and SenesTech Inc. (SNES): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBUS and SNES operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- CBUS is the larger of the two at $128.4M, about 20.4x SNES ($6.3M).
- SNES has been more active in the news (9 items in the past 4 weeks vs 3 for CBUS).
- CBUS has more recent analyst coverage (4 ratings vs 0 for SNES).
- Company
- Cibus Inc.
- SenesTech Inc.
- Price
- -
- -
- Market cap
- $128.4M
- $6.3M
- 1M return
- -13.92%
- -
- 1Y return
- +21.90%
- -
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- 2016
- News (4w)
- 3
- 9
- Recent ratings
- 4
- 0
SNES
SenesTech Inc.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Latest CBUS
- SEC Form 10-Q filed by Cibus Inc.
- Cibus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Cibus Reports Second Quarter Financial Results and Provides Business Update
- Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call
- SEC Form S-8 filed by Cibus Inc.
- SEC Form S-8 filed by Cibus Inc.
- Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus
- CEO Wichner Craig was granted 894,309 shares (SEC Form 4)
- Cibus Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation
Latest SNES
- SEC Form S-8 filed by SenesTech Inc.
- Chief Executive Officer Edell Michael bought $1,210 worth of shares (1,000 units at $1.21), increasing direct ownership by 20% to 6,000 units (SEC Form 4)
- SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026
- Large owner Glenbrook Capital Management bought $27,865 worth of shares (21,490 units at $1.30) (SEC Form 4)
- SenesTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth Accelerates
- SenesTech Adds Assessment Services to Help B2B Customers Better Understand Rodent Infestations
- SenesTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum
- SenesTech to Report Second Quarter 2026 Financial Results on Wednesday, August 5, 2026